Search Results 21-30 of 17379 for GLP-1 medications

  1. Diabetes treatment disparities widespread, room for improvement

    Two diabetes prescriptions that have benefits beyond lowering blood sugar are GLP-1 receptor agonist (GLP-1RA) and SGLT2 inhibitor (SGLT2i) medications. For ...

  2. Examining the impact of GLP-1 receptor agonist use on quality of bowel preparation for colonoscopy - Mayo Clinic

    "These medications are known to delay gastrointestinal motility, which can adversely affect bowel preparation quality for colonoscopy," says Dr. Coelho-Prabhu.

  3. Lixisenatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Lixisenatide is used together with diet and exercise to help control your blood sugar. This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. This ...

  4. Mayo Clinic Q & A: Supporting weight-loss medications with adequate, tailored nutrition

    Medications for obesity approved by the Food and Drug Administration often work by decreasing appetite and increasing fullness. Popular glucagon-like peptide 1 ...

  5. Bariatric Center in Jacksonville - Your first appointment - Mayo Clinic

    Prescription medications to treat obesity may be an option to help ... Any prescriptions provided by your doctor, such as glucagon-like peptide 1 (GLP ...

  6. Using technology to remove barriers to bariatric surgery - Mayo Clinic

    ... medications and lifestyle interventions. The growing interest in GLP-1 RAs may be due to misperceptions about surgical risk and the fact that preparation ...

  7. Science Saturday: Diabetes treatment disparities widespread, room for improvement

    McCoy. Two diabetes prescriptions that have benefits beyond lowering blood sugar are GLP-1 receptor agonist (GLP-1RA) and SGLT2 inhibitor (SGLT2i) medications.

  8. Why gastroenterologists and hepatologists should be involved in treating obesity - Mayo Clinic

    Incretin-modifying agents, including glucagon-like peptide-1 (GLP-1) receptor agonists, are emerging as the most promising drug treatments for obesity ...

  9. Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in Type 1 and Type 2 Diabetes - Mayo Clinic

    ... GLP-1. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.